 |
|
|
|
December 2000 Cover
|
|
Dr. Ronald Mitsuyasu, director of the University of California at Los Angeles AIDS Research and Education Center, announced at the fifth International Congress on Drug Therapy in HIV Infection that adding an immune booster to normal HIV therapy helps patients. Mitsuyasu and colleagues administered the immune booster interleukin-2 (IL-2) to the drug cocktails of one group of patients, while another group received only highly active antiretroviral therapy (HAART). The patients taking the IL-2 in addition to HAART
saw significant increases in CD4 cells and also reported fewer episodes of AIDS-related illnesses.
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
